Asambly Chemicals Co. Ltd.

Home
Products
About Us
Factory Tour
Quality Control
Contact Us
Request A Quote
News
Home ProductsLinagliptin Drug

CAS 853029 57 9 Linagliptin Drug Intermediate GMP Condition C20H17BrN6O2

I'm Online Chat Now

CAS 853029 57 9 Linagliptin Drug Intermediate GMP Condition C20H17BrN6O2

China CAS 853029 57 9 Linagliptin Drug Intermediate GMP Condition C20H17BrN6O2 supplier

Large Image :  CAS 853029 57 9 Linagliptin Drug Intermediate GMP Condition C20H17BrN6O2

Product Details:

Place of Origin: China
Certification: GMP condition

Payment & Shipping Terms:

Minimum Order Quantity: 1KG
Packaging Details: Drum
Contact Now
Detailed Product Description
CAS: 853029-57-9 Usage: Linagliptin Intermediate
Molecular: C20H17BrN6O2
High Light:

51019 43 3

,

764 01 2

CAS : 853029-57-9 Linagliptin Intermediate GMP condition

 

Chemical Name : 1 - [ ( 4 - Methylquinazolin - 2 - yl ) methyl ] - 3 - methyl - 7 - ( 2 - butyn - 1 - yl ) - 8 - bromoxanthine

 

CAS No . : 853029-57-9

 

Synonym : 8 - Bromo - 7 - ( 2 - butyn - 1 - yl ) - 3 , 7 - dihydro - 3 - methyl - 1 - [ ( 4 - methyl - 2 - quinazolinyl ) methyl ] - 1H - purine - 2 , 6 - dione

 

Molecular Formula : C20H17BrN6O2

 

Molecular Weight : 453.29

 

Usage : Linagliptin Intermediate

 

Description: Linagliptin is the active pharmaceutical ingredient (API) of branded drug Tradjenta, Trajenta or Trazenta. It was innovated by the Germany drug maker Boehringer Ingelheim and cooperated the marketing with Lily. Linagliptin was approve by the US FDA in 2011. Linagliptin is used for the treatment of type 2 diabetes. Linagliptinis is a Dipeptidyl peptidase-4 inhibitor (DPP-4, DPP-IV).

 

1 - [ ( 4 - Methylquinazolin - 2 - yl ) methyl ] - 3 - methyl - 7 - ( 2 - butyn - 1 - yl ) - 8 - bromoxanthine CAS No . : 853029-57-9 is one of its intermediates. There are several synthesis routes to manufacture this intermediate but some routes are protected by the patents in some countries including Europe, USA and China. We strictly obey the laws and our products are for R&D purpose. But anyway, the buyers should know the patent status by themselves. We promise to supply the real route of synthesis to the buyers. The buyers should take the risks of patent infringement by themselves.

 

Competitive Advantage: Produced under cGMP conditions, support customers’ registrations.

 

Contact Details
Asambly Chemicals Co. Ltd.

Contact Person: MAO Xiaolong

Send your inquiry directly to us (0 / 3000)